Investing in 4.0 Makes Both Technological and Financial Sense
Pharma 4.0 looks to be a total strategic move as biopharmaceutical manufacturing plants become ecosystems of intensified, connected operations.
Related Articles
Cytiva Introduces Its Xcellerex Magnetic Mixer at Interphex
Cytiva notes that its magnetic mixing system can meet the many demands and constraints during buffer and cell culture media preparation.
Accelerating Progress in Cell and Gene Therapy
Azenta Life Sciences addresses cryopreservation scalability and standardization challenges.
Asahi Kasei and Axolabs Partner on Oligonucleotide Therapeutics
Asahi Kasei and Axolabs will collaborate to build an oligo GMP manufacturing facility spanning an area of 59,000 square feet in Berlin.
Merck Launches All-in-One Genetic Stability Assay for Biosafety Testing
Currently, FDA guidance requires biotech companies to use multiple assays to address genetic stability requirements. This traditional package of assays is costly, time-consuming, and often…
Model Predicts RTD—with Variations—for Continuous Processing
Regulators advise resident time distribution (RTD) studies as a way to address issues between batch processing and continuous manufacturing of biologics.
Comparing pH Sensors for Upstream Bioprocessing
When testing sensors in upstream bioprocessing, electrochemical sensors were more accurate than optical pH sensors, but less accurate as a batch of cells aged.
Online Event
Workflow design and data management are pivotal components of cell and gene therapy research and development. Advances in artificial intelligence, informatics, and automation have made…
Gene Network Interactions Shed Insight into Breast Cancer Onset and Development
A new study has identified differential gene-network changes characteristic of the three most prevalent molecular subtypes of breast cancer, Luminal A, Luminal B, and the…
At Bio-IT World 2024, AI Applications Take Center Stage
From the keynotes to the tracks, conversations around AI-based applications were top of mind at this year’s meeting.
Online Event
In this webinar, Jeff Coller, PhD, will describe a new therapeutic technique that enhances mRNA translation. This technology has numerous clinical applications and works by…